Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Researchers set to test nasal spray for COVID-19 as part of a clinical trial

Staff Writer
Staff Writer 1 year ago
Updated 2021/12/29 at 2:04 AM
Share
SHARE

Experts at the University of Melbourne and Monash University are set to test out a nasal spray treatment for COVID-19 amid a $4.2 million funding plan for a six-month clinical trial.

Researchers used heparin as the base of the nasal spray treatment given its simplicity to administer and use.

“Basic science studies revealed that intranasal heparin may be an effective way to prevent COVID-19 infection and spread. COVID-19 first infects cells in the nose, and to do that the virus must bind to Heparan Sulfate on the surface of nasal cells lining the nose,” according to one co-researcher.

The nasal spray treatment contains the active ingredient of heparin that is structurally similar to Heparan Sulfate and can inhibit the spreading of the coronavirus.


“Importantly, this nasal spray should prove effective for all COVID-19 variants because the Heparan Sulfate binding site is essential for infection, and is likely to be preserved in new variants. Heparin binds avidly to the Omicron variant currently sweeping through the country,” one researcher explained in a news release.

“It is now essential that we test the actual effectiveness of Heparin in the rigorously designed, double blinded, placebo controlled clinical trial as this will provide definitive evidence. If the treatment is proven to work in the setting of preventing progression and spread within homes, it would support using the spray to protect highly vulnerable populations such as the elderly, pregnant women, and those with weak immune systems.”

Photo: Getty Images

You Might Also Like

Study shows how the gut microbiome can be altered by youth binge drinking

Study finds calcium channels help regulate neuroinflammation and neuropathic pain

Machine learning research suggests drugs that may decrease cigarette smoking

New research explores the association between viral infection and Alzheimer’s disease

Study suggests mindfulness may help adolescents overcome traumas

TAGGED: COVID-19, epidemiology
Staff Writer December 28, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Nearly three-in-ten adults in America report having no religious affiliation
Next Article How a healthy diet that reduces inflammation may also lower the risk of gestational diabetes

Recommended

Health

Study shows how the gut microbiome can be altered by youth binge drinking

1 Min Read
Health

Study finds calcium channels help regulate neuroinflammation and neuropathic pain

1 Min Read
Health

Machine learning research suggests drugs that may decrease cigarette smoking

1 Min Read
Health

New research explores the association between viral infection and Alzheimer’s disease

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?